| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | | Total Revenue | 5,970 | 1,950 | | Cost of Revenue | 1,177 | 678 | | | Gross Profit | 4,793 | 1,271 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 167 | 100 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 4,626 | 1,171 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (58,673) | (14,931) | | Earnings Before Interest And Taxes | 4,626 | 823 | | Interest Expense |
-
|
-
| | Income Before Tax | 4,626 | 823 | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (54,047) | (13,760) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (54,047) | (13,760) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($54,047) | ($13,760) |
|
1.27% Nasdaq 
Income Statement
